# Progress Note 04 — Sick Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Lorraine Hansberry (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML034-SYN-TD
- Date: 1963-07-16
- Fictional facility: St. Posthumous Health Center
- Fictional author: Odette Marchetti-Fields, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Sick Visit
- Services: Problem-oriented office visit, established patient, with intravenous fluids in the infusion center

## Chief complaint

Watery diarrhea since yesterday, three days after chemotherapy. **S**

## History of present illness

Ms. Hansberry called the oncology line on day 4 of her fifth cycle of modified FOLFIRINOX and was seen the same day. The pump was disconnected two days ago and pegfilgrastim given. Since yesterday afternoon she has had six watery stools, two of them overnight, and mild cramping. She took loperamide 4 mg at the first loose stool and 2 mg after each one since, eight tablets in all. Her stools are not pale or greasy as they were before pancrelipase, and there is no blood or black stool. She has had no fever (highest 37.2 °C at home), vomiting, or antibiotics, and no one around her is ill. She feels light-headed when she stands and has been drinking less than usual because of the cramps. She is eating little. Her blood glucose readings at home have been 110 to 150 mg/dL. She was writing every morning last week and wants to be back at her desk by the weekend. She has had no thoughts of self-harm. **S**

| Element | Detail |
|---|---|
| Onset | Yesterday afternoon, on day 3 of cycle 5 |
| Severity | Six watery stools a day above her usual; cramping; no blood |
| Context | Irinotecan late diarrhea is expected two to ten days after a dose; pegfilgrastim given two days ago |
| Treatment so far | Loperamide 4 mg, then 2 mg after each loose stool: eight tablets |
| Associated signs and symptoms | Light-headed on standing; no fever, vomiting, blood, or antibiotic use |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired and light-headed on standing; no fever or chills |
| Gastrointestinal | Positive | Watery diarrhea and cramping; no blood, black stool, or vomiting |
| Genitourinary | Positive | Passing less urine than usual |
| Cardiovascular | Negative | No chest pain or leg swelling |
| Endocrine | Negative | Home glucose 110 to 150 mg/dL; no low readings |
| Psychiatric | Negative | Frustrated at losing writing days; no thoughts of self-harm |

6 systems reviewed. **S**

## Current medications

- Pantoprazole 40 mg delayed-release oral tablet, one tablet by mouth once daily before breakfast **S**
- Oxycodone 5 mg oral tablet, one tablet by mouth every 4 hours as needed for pain **S**
- Senna 8.6 mg oral tablet, two tablets by mouth at night while taking oxycodone **S**
- Pancrelipase delayed-release capsule (lipase 36,000 units), two capsules with each meal and one with each snack **S**
- Oxaliplatin 5 mg/mL injection, 135 mg (85 mg/m2) intravenously over 2 hours on day 1 of each 14-day cycle, for six cycles **S**
- Leucovorin 10 mg/mL injection, 634 mg (400 mg/m2) intravenously over 2 hours on day 1 of each 14-day cycle, for six cycles **S**
- Fluorouracil 50 mg/mL injection, 3800 mg (2400 mg/m2) by continuous infusion over 46 hours through the port from day 1 of each 14-day cycle, for six cycles, with no bolus **S**
- Pegfilgrastim 6 mg/0.6 mL prefilled syringe, 6 mg under the skin on day 3 of each cycle, after the pump is disconnected **S**
- Ondansetron 8 mg oral tablet, one tablet by mouth every 8 hours as needed for nausea **S**
- Olanzapine 5 mg oral tablet, one tablet by mouth at night on days 1 to 4 of each cycle **S**
- Loperamide 2 mg oral capsule, two capsules at the first loose stool, then one after each loose stool, no more than eight a day unless directed **S**
- Apixaban 2.5 mg oral tablet, one tablet by mouth twice daily during chemotherapy, stopped three days before surgery **S**
- Potassium chloride 20 mEq extended-release tablet, two tablets by mouth today, then one tablet daily for three days **S**

## Allergies

- No known allergy **S**

## Objective

BP 98/62 mmHg; pulse 104 bpm; respirations 16/min; temperature 37.1 °C; oxygen saturation 99% on room air; weight 53.6 kg; BMI 20.2 kg/m². All vital signs are synthetic.

Hemoglobin: 11 g/dL (low); White cell count: 6.2 10*3/uL; Absolute neutrophil count: 4.1 10*3/uL; Platelets: 188 10*3/uL; Sodium: 134 mmol/L (low); Potassium: 3.2 mmol/L (low); Creatinine: 0.94 mg/dL; eGFR (CKD-EPI 1958): 83 mL/min/1.73 m²; Glucose: 118 mg/dL (high); Magnesium: 1.6 mg/dL (low). All results are synthetic.

## Change since baseline

- Hemoglobin: 9.1 g/dL (low) at baseline, 11 g/dL (low) at this visit **S**
- White cell count: 7.4 10*3/uL at baseline, 6.2 10*3/uL at this visit **S**
- Platelets: 388 10*3/uL at baseline, 188 10*3/uL at this visit **S**
- Sodium: 138 mmol/L at baseline, 134 mmol/L (low) at this visit **S**
- Potassium: 4 mmol/L at baseline, 3.2 mmol/L (low) at this visit **S**
- Creatinine: 0.7 mg/dL at baseline, 0.94 mg/dL at this visit **S**
- eGFR (CKD-EPI 1958): 118 mL/min/1.73 m² at baseline, 83 mL/min/1.73 m² at this visit **S**
- Glucose: 132 mg/dL (high) at baseline, 118 mg/dL (high) at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Tired but alert; weight 53.6 kg, down 1.2 kg from the weight at cycle 4; temperature 37.1 °C |
| Vital signs | Lying 104/66 with pulse 96; standing 96/60 with pulse 112 and light-headedness: orthostatic |
| Head, eyes, ears, nose, and throat | Dry mouth; no mouth sores |
| Abdomen | Soft, mildly tender in the lower abdomen without guarding; active bowel sounds; no distension |
| Skin | Port site clean; no jaundice |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Chemotherapy-induced diarrhea, grade 2, from irinotecan** (K52.1). Late irinotecan diarrhea, grade 2, with mild dehydration (orthostatic, creatinine 0.94 from 0.72) and losses of potassium (3.2) and magnesium (1.6). No fever, the neutrophil count is 4.1, and she has had no antibiotics, so this is uncomplicated; a stool test for Clostridioides difficile toxin was sent as a precaution and was negative later today. Not steatorrhea: the stools are watery, not pale or greasy, and she is taking pancrelipase with every meal. **S**
   - One liter of normal saline in the infusion center today, with magnesium sulfate 2 g intravenously.
   - Potassium chloride 40 mEq by mouth today, then 20 mEq daily for three days.
   - Loperamide 4 mg now, then 2 mg every two hours (4 mg every four hours at night) until 12 hours pass without a loose stool; oral rehydration solution.
   - Call at once for fever of 38.0 °C or more, blood in the stool, fainting, or diarrhea lasting beyond 24 hours on this regimen; that would need admission and octreotide.
   - Irinotecan reduced by one dose level (to 120 mg/m2) for cycle 6, as Dr. Adeyemi-Rourke's team agreed.
2. **Diabetes due to the pancreatic cancer** (E08.9). Glucose 118 mg/dL; eating little, so no change. **S**
   - Continue home glucose checks.
3. **Pancreatic head adenocarcinoma, borderline resectable, on modified FOLFIRINOX** (C25.0). Cycle 5 of six given on schedule; CA 19-9 falling at cycle 4. **S**
   - Cycle 6 in 11 days if the diarrhea has settled and the potassium is normal.

## Medication changes

- Started: Potassium chloride 20 mEq extended-release tablet, two tablets by mouth today, then one tablet daily for three days **S**

## Guideline basis

- NCCN Clinical Practice Guidelines in Oncology: Pancreatic Adenocarcinoma (2026), National Comprehensive Cancer Network
- Benson AB 3rd, et al. Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J Clin Oncol 2004;22(14):2918-2926 (PMID 15254061) (2004), Journal of Clinical Oncology

## Follow-up

- Phone call tomorrow morning and blood test (potassium, magnesium, creatinine) in two days. Cycle 6 as booked if recovered. **S**
- Next scheduled visit 1963-08-10: after six cycles: restaging CT and CA 19-9, decision for surgery, and preparation for pancreaticoduodenectomy. **S**
